ClinicalTrials.gg
Sign In

Drug

Glucagon-like peptide 1 (7-36)amide clinical trials

studies test it
5
open now
2
in phase 3
0
first study started
2007

Keep track of what changes. Save the glucagon-like peptide 1 (7-36)amide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Combined with it in one product

MKC253 Inhalation Powder
2
GIP/GLP-1a
1

Studies by the year they started

5 studies that test it; most in 2007 (1)

Studies that test glucagon-like peptide 1 (7-36)amide, by start year
YearStudies
20071
20081
20151
20231
20241

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
1
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Diabetes Mellitus, Type 2
2
Coronary Stenosis
1
Prediabetic State
1
Non-alcoholic Fatty Liver Disease
1

Who runs them

Industry 2 · Other 3

Mannkind Corporation (2) · Papworth Hospital NHS Foundation Trust (1) · Stanford University (1) · Dr Adnan Agha (1)

Often tested with

Tested in the same studies.

Beinaglutide (2) · Metformin (1) · Gastric Inhibitory Polypeptide (1)

Studies

Open first, then newest update. How each study uses glucagon-like peptide 1 (7-36)amide is read from its arms, and is right about nine times in ten.

Testing it · 5